Indomethacin and thromboxane A2/prostaglandin H2 antagonist SQ29,548 impair in vitro contractions of aortic rings of ex vivo-treated lipopolysaccharide rats

Journal of Lipid Mediators and Cell Signalling

Volumn 13, Issue 2, 1996, Pages 177-187

  Cirino, Giuseppe ^a   Sorrentino, Raffaella ^a   Cicala, Carla ^a   Sorrentino, Ludovico ^a   Pinto, Aldo ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Dept of Experimental Pharmacology ^*  (Italy)

Author keywords

Dexamethasone; Hypocontractility; Indomethacin; Lipopolysaccharide; Thromboxane A2 receptor antagonist

Indexed keywords

7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; DEXAMETHASONE; INDOMETACIN; LIPOPOLYSACCHARIDE; PHENYLEPHRINE; POTASSIUM CHLORIDE; THROMBOXANE A2 RECEPTOR; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; 6 OXOPROSTAGLANDIN F1 ALPHA; HYDRAZINE DERIVATIVE; POTASSIUM; PROSTAGLANDIN H; PROSTAGLANDIN H2; THROMBOXANE B2; THROMBOXANE RECEPTOR;

ANIMAL EXPERIMENT; AORTA; ARTICLE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BLOOD PRESSURE; DRUG ANTAGONISM; DRUG EFFECT; IN VITRO STUDY; METABOLISM; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; WISTAR RAT;

6-KETOPROSTAGLANDIN F1 ALPHA; ANIMALS; AORTA; BLOOD PRESSURE; HYDRAZINES; INDOMETHACIN; LIPOPOLYSACCHARIDES; MALE; MUSCLE, SMOOTH, VASCULAR; PHENYLEPHRINE; POTASSIUM; PROSTAGLANDIN H2; PROSTAGLANDINS H; RATS; RATS, WISTAR; RECEPTORS, THROMBOXANE; THROMBOXANE B2; VASOCONSTRICTION;

EID: 0029665629     PISSN: 09297855     EISSN: None     Source Type: Journal    
DOI: 10.1016/0929-7855(95)00051-8     Document Type: Article

References (26)

1. Ball, R.A., Cook, J.A., Wise, W.C. and Halushka, P.V. (1986) Role of thromboxane, prostaglandins and leukotrienes in endotoxin and septic shock. Intensive Care Med. 12, 116-120.
2. Bigaud, M., Joulou-Schaeffer, G., Parrat, J.R. and Stoclet, J. (1990) Endotoxin-induced impairment of vascular smooth muscle contractions elicited by different mechanisms. Eur. J. Pharmacol. 190, 185-192.
3. Bottoms, G.D., Templeton, C.B., Fessier, J.F., Johnson, M.A., Roesel, O.F., Evert, K.M. and Adams, S.B. (1982) Thromboxane, prostaglandin 12 (epoprostenol) and the hemodynamic changes in equine endotoxin shock. Am. J. Vet. Res. 43, 999-1003.
4. Fleming, I., Gray, G.A., Joulou-Schaeffer, G., Parrat, J.R. and Stoclet, J.C. (1990) Incubation with endotoxin activates the L-arginine pathway in vascular tissue. Biochem. Biophys. Res. Commun. 171, 562-565.
5. Fletcher, J.R. and Ramwell, P.W. (1977) Modification by aspirin and indomethacin of the hemodynamic and prostaglandin releasing effects of E. coli endotoxin in the dog. Br. J. Pharmacol. 61, 175-181.
6. 2 enzymes: regulation and inhibition. Trends Pharmacol. Sci. 14, 92-98.
7. Gryglewski, R.J., Botting, R.M. and Vane, J.R. (1988) Mediators produced by endothelial cells. Hypertension 12, 530-548.
8. Groeneveld, A.B.J. and Thijs, L.G. (1986) Hemodynamic determinants of mortality in human septic shock. Surgery 99, 140-143.
9. Joulou-Schaeffer, G., Gray, G.A., Fleming, I., Scott, C., Parrat. J.R. and Stoclet, J. (1990) Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am. J. Physiol. 259, H1038-H1043.
10. Joulou-Schaeffer, G., Gray, G.A., Fleming, I., Scott, C., Parratt, J.R. and Stoclet, J. (1991) Activation of the L-arginine-nitric oxide pathway is involved in vascular hyporeactivity induced by endotoxin. J. Cardiovascular Pharmacol. 17 (Suppl. 3), S207-S212.
11. McKenna, T.M. (1990) Prolonged exposure of rat aorta to low levels of endotoxin in vitro results in impaired contractility. J. Clin. Invest. 86, 160-168.
12. Mozes, T., Zijlstra, F.J., Heiligers, J.P.C., Tak, C.J.A.M., Ben-Efraim, S., Bonta, L. and Saxena, P.R. (1991) Sequential release of tumor necrosis factor and eicosanoids during endotoxin shock in anaesthetized pigs, protective effect of indomethacin. Br. J. Pharmacol. 104, 691-699.
13. Nakaki, T., Otsuka, Y., Nakayama, M. and Kato, R. (1992) Endothelium-accelerated hyporesponsiveness of norepinephrine-elicited contraction of rat aorta in the presence of bacterial lipopolysaccharide. Eur. J. Pharmacol. 219, 311-318.
14. 2 in the tissues of endotoxin shock rats and its suppression by glucocorticoid. FEBS Lett. 273, 23-26.
15. Oettinger, W. (1983) Contribution of the prostaglandin system to the pathogenesis of clinical and experimental septic shock. In Lewis, D.H. and Haglund, U. (Eds), Shock Research, Elsevier, Amsterdam, p. 43.
16. Pittet, J.F. and Morel, D.R. (1991) Imbalance between plasma levels of thromboxane B2 and 6-keto-prostaglandin F1α during subacute endotoxin-induced hyperdynamic sepsis or multiple organ failure syndrome in sheep. Circ. Shock 35, 65-71.
17. 2 in human volunteers challenged with intravenous endotoxin. Inflammation 16, 561-570.
18. 2 receptor in the vasoconstrictor response of rat aorta to endothelin. J. Pharmacol. Exp. Ther. 252, 915-921.
19. Suba, A., Mc Kenna, M. and Williams, T.J. (1992) In vivo and in vitro effects of endotoxin on vascular responsiveness to norepinephrine and signal transduction in rats. Circ. Shock, 127-133.
20. Tallarida, R.J. and Murray, R.B. (1987) Manual of Pharmacological Calculations, 2nd Edn, Springer, New York.
21. Thiemermann, C. and Vane, J.R. (1990) Inhibition of nitric oxide synthesis reduce the hypotension in the rat in vivo. Eur. J. Pharmacol. 182, 591.
22. 2 in the pathogenesis of the hemodynamic changes in endotoxin shock. Can. J. Physiol. 61, 561-566.
23. Wakabayashi, I., Hatake, K., Kakishita, E. and Nagai, K. (1987) Diminution of contractile response of the aorta from endotoxin-injected rats. Eur. J. Pharmacol. 141, 117-122.
24. Wakabayashi, I., Hatake, K. and Sakamoto, K. (1991) Mechanisms of ex vivo aortic hypocontractility in endotoxemic rat. Eur. J. Pharmacol. 199, 115-118.
25. Wright, C.E., Rees, D.D. and Moncada, S. (1992) Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc. Res. 26, 48-57
26. Young, J.S., Headrick, J.P. and Berne, R.M. (1991) Endothelial-dependent and independent response in the thoracic aorta during endotoxin shock. Circ. Shock 35, 25-29